secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vistagen Therapeutics, Inc. (VTGN)
CIK:        0001411685
Form:       8-K
Filed at:   2022-05-03T23:59:59+00:00
Accession:  0001437749-22-010697
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VistaGen appoints Reid Adler as Chief Legal Officer effective May 2, 2022
-------------------------------------------------------------------------

- Reid G. Adler appointed CLO; will oversee legal affairs and provide strategic guidance to Executive Team and Board.
- Adler previously founded Capital Technology Law Group and had represented VistaGen as outside counsel.
- Career includes partner at Morrison & Foerster and Morgan Lewis, general counsel at J. Craig Venter Institute.
- Adler was founding director of NIH Office of Technology Transfer, building a team of over 40 people.
- Company paid Capital Technology Law Group $210,000 in FY ended March 2022 and $18,000 in April 2022 for legal services.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411685/000143774922010697/0001437749-22-010697-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411685/000143774922010697/vtgn20220502_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-010697

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer